Serum adiponectin, hs- C-reactive protein and tumor necrosis factor-alpha levels In patients with obstructive sleep apnea syndrome: Effect of CPAP Source: Annual Congress 2010 - Biomarkers for oxidative stress, inflammation and cardiovascular function in sleep apnoea Year: 2010
Frequency of distribution of IL-1, IL-6 and TNFa gene polymorphism in patients with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2006 - Metabolic control in obstructive sleep apnoea Year: 2006
Determinant factors of serum leptin levels in patients with obstructive sleep apnea Source: Annual Congress 2005 - Metabolic control in OSA Year: 2005
Obstructive sleep apnea syndrome in obese patients: adiponectin levels Source: Annual Congress 2005 - Metabolic control in OSA Year: 2005
Tumour necrosis factor-α (-308) gene polymorphism in obstructive sleep apnoea-hypopnoea syndrome Source: Eur Respir J 2005; 26: 673-678 Year: 2005
Can leptin and IL-6 influence the nutritional status in COPD patients? Source: Annual Congress 2006 - COPD and systemic inflammation Year: 2006
Metabolic consequences in obstructive sleep apnoea Source: Annual Congress 2006 - PG9 - Obstructive sleep apnoea: current pathophysiological, clinical and therapeutic concepts Year: 2006
Production of TNF-α, MMPs, and MCP-1 by monocytes and hypoxic stress in patients with obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2004; 24: Suppl. 48, 331s Year: 2004
Plasma levels of TNF in obstructive sleep apnea syndrome (OSA) before and after surgical intervention Source: Annual Congress 2012 - Clinical predictors of OSA, adherence to CPAP and psychology Year: 2012
The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 113s Year: 2004
Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment Source: Eur Respir J 2003; 22: 251-257 Year: 2003
Airway‘s leptin, body mass index and obstructive sleep apnea: is there any correlation? Source: Eur Respir J 2006; 28: Suppl. 50, 412s Year: 2006
The influence of obstructive sleep apnoea and obesity on adiponectin, leptin, IGFBP-1 and HOMA-IR Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing Year: 2013
Metabolic disturbances in patients with obstructive sleep apnoea syndrome Source: Eur Respir Rev 2007; 16: 196-202 Year: 2007
The role of pro- and anti- inflammatory cytokines in the pathogenesis of obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea Year: 2008
The impact of serum leptin and soluble leptin receptor (sOB-R) levels on respiratory chemosensitivities in obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2006; 28: Suppl. 50, 413s Year: 2006
BNP or VEGF levels do not predict disease severity in obstructive sleep apnoea syndrome (OSAS) Source: Eur Respir J 2005; 26: Suppl. 49, 40s Year: 2005
Relationship between body mass index (BMI), tumour-necrosis factor-alpha (TNFα) and bone density in chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 214s Year: 2001
Plasma vascular endothelial growth factor levels in patients with obstructive sleep apnea hypopnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 564s Year: 2004
Interaction between body weight obstructive sleep apnea (OSA) on C-reactive protein (CRP) in an otherwise healthy population: The EPIOSA study Source: International Congress 2015 – Ring of fire: inflammation and metabolism in sleep-disordered breathing Year: 2015